Your browser doesn't support javascript.
loading
Assessment of hepatitis E seropositivity among HIV-infected patients in Bulgaria
Golkocheva-Markova, Elitsa; Kevorkyan, Ani; Raycheva, Ralitsa; Ismailova, Chiydem; Yoncheva, Viliana; Tenev, Tencho; Emilova, Radoslava; Grigorova, Lyubomira; Baltadzhiev, Ivan; Komitova, Radka.
Afiliação
  • Golkocheva-Markova, Elitsa; National Center of Infectious and Parasitic Diseases. Virology Department. Sofia. BG
  • Kevorkyan, Ani; Medical University-Plovdiv. Faculty of Public Health. Department of Epidemiology and Disaster Medicine. Plovdiv. BG
  • Raycheva, Ralitsa; Medical University -Plovdiv. Faculty of Public Health. Department of Social Medicine and Public Health. Plovdiv. BG
  • Ismailova, Chiydem; National Center of Infectious and Parasitic Diseases. Virology Department. Sofia. BG
  • Yoncheva, Viliana; National Center of Infectious and Parasitic Diseases. Virology Department. Sofia. BG
  • Tenev, Tencho; National Center of Infectious and Parasitic Diseases. Virology Department. Sofia. BG
  • Emilova, Radoslava; National Center of Infectious and Parasitic Diseases. Department of Immunology and Allergology. Sofia. BG
  • Grigorova, Lyubomira; National Center of Infectious and Parasitic Diseases. Virology Department. Sofia. BG
  • Baltadzhiev, Ivan; Medical University-Plovdiv. Faculty of medicine. Plovdiv. BG
  • Komitova, Radka; Medical University-Plovdiv. Faculty of medicine. Plovdiv. BG
Braz. j. infect. dis ; 26(1): 102329, 2022. tab, graf
Article em En | LILACS-Express | LILACS | ID: biblio-1364547
Biblioteca responsável: BR1.1
ABSTRACT
Abstract It is debatable whether HIV-infected patients are at greater risk for hepatitis E virus (HEV) infection compared with healthy subjects. The reported anti-HEV seroprevalence among different groups in Bulgaria varied from 9.04% to 25.9%, but the information regarding the HIV population is still missing. The aim of the present study was to evaluate hepatitis E seroprevalence among HIV-infected patients in Bulgaria and to analyze demographic and immunological factors associated with HEV infection. Serum samples of 312 HIV-infected patients were analyzed retrospectively. Age, sex, residence and laboratory markers for HEV, HBV, HCV and HIV infection, and lymphocytes subpopulations were collected for all patients. None of the tested samples were positive for HEV RNA. HEV seroprevalence among HIV-infected patients was 10.9%. Males were more affected with the highest prevalence of positivity in the age group > 30 to ≤ 40 years. The documented HIV transmission routes in HIV/HEV co-infected group were heterosexual, homosexual, intravenous drug use (IDU), and vertical with predominace of the heterosexual route (z = 0.2; p = 0.804). There was a statistically significant trend of HIV mixed infection with routes of HIV transmission other than homosexual - heterosexual in HIV/HEV group and injection drug use in HIV/HBV/HCV co-infected group. The route of HIV transmission, in contexts of patients' behavior, was associated with HEV prevalence among HIV-infected patients.
Palavras-chave

Texto completo: 1 Base de dados: LILACS Idioma: En Ano de publicação: 2022 Tipo de documento: Article / Project document

Texto completo: 1 Base de dados: LILACS Idioma: En Ano de publicação: 2022 Tipo de documento: Article / Project document